Marshak Richard
SEC CIK 1982638 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TLSI | TriSalus Life Sciences, Inc. | SR.VP, CORP. DEV, STRATEGY | 128.3K | — | $49.8K | 10 | 2024-02-12 | 2026-06-30 |
Most active insiders at TLSI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Stansky Michael P | Dir | $3.01M | — |
| 2 | Szela Mary T | CEO, Pres, Dir | $227.8K | $79.4K |
| 3 | Wahlstrom Mats | Dir | $151.8K | — |
| 4 | Valle William | Dir | $125.0K | — |
| 5 | Gordon Gary B. | Dir | $64.6K | — |
| 6 | Patience David | CFO | $32.2K | — |
| 7 | Marshak Richard | Chief Commercial Off | — | $15.7K |
| 8 | Stevens Jennifer | Chief Regulatory Off | — | $14.5K |
| 9 | Devlin Jodi | Chief of Clinical Ops | — | $13.2K |
| 10 | Cox Bryan F. | Chief of Research | — | $13.1K |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-01 16:02 | 2026-06-30 | TLSI | TriSalus Life Sciences, Inc. | Marshak Richard | Chief Commercial Off | A - Grant | $3.87 | +561 | 128.3K | +0.4% | +$2,171 | |
| 2026-05-19 16:08 | 2026-05-15 | TLSI | TriSalus Life Sciences, Inc. | Marshak Richard | Chief Commercial Off | S - Sale | $2.67 | -543 | 125.1K | -0.4% | -$1,450 | |
| M | 2026-03-20 | 2026-03-11+ | TLSI | TriSalus Life Sciences, Inc. | Marshak Richard | Chief Commercial Off | S - Sale | $4.11 | -3,457 | 110.8K | -3% | -$14.2K |
| D | 2025-11-25 | 2025-11-24 | TLSI | TriSalus Life Sciences, Inc. | Marshak Richard | Chief Commercial Off | A - Grant | $0.00 | +60.0K | 113.9K | +111% | $0 |
| 2025-05-21 | 2025-05-19 | TLSI | TriSalus Life Sciences, Inc. | Marshak Richard | Chief Commercial Off | S - Sale | $5.18 | -6,597 | 69.1K | -9% | -$34.2K | |
| 2025-05-21 | 2025-05-19 | TLSI | TriSalus Life Sciences, Inc. | Marshak Richard | Chief Commercial Off | A - Grant | $5.18 | +21.4K | 75.7K | +39% | +$111.0K | |
| 2025-02-19 | 2025-02-18 | TLSI | TriSalus Life Sciences, Inc. | Marshak Richard | Chief Commercial Off | A - Grant | $0.00 | +7,644 | 54.3K | +16% | $0 | |
| D | 2025-01-29 | 2025-01-27 | TLSI | TriSalus Life Sciences, Inc. | Marshak Richard | Chief Commercial Off | A - Grant | $0.00 | +12.5K | 46.6K | +37% | $0 |
| D | 2024-11-15 | 2024-11-14 | TLSI | TriSalus Life Sciences, Inc. | Marshak Richard | SR.VP, CORP. DEV, STRATEGY | A - Grant | $0.00 | +6,875 | 34.1K | +25% | $0 |
| D | 2024-02-14 | 2024-02-12 | TLSI | TriSalus Life Sciences, Inc. | Marshak Richard | SR.VP, CORP. DEV, STRATEGY | A - Grant | $0.00 | +14.8K | 27.3K | +118% | $0 |
Purchase Sale Sale after option exercise All abbreviations